Altesa BioSciences is a clinical-stage pharmaceutical company, led by global experts in respiratory medicine and infectious diseases. Altesa is dedicated to improving the lives of people with chronic lung diseases, like COPD and asthma, by treating the principal cause of exacerbations and pathological inflammation - viral respiratory infections. In addition to advancing vapendavir, their lead medicine, Altesa advocates for improved access to modern respiratory diagnostics and therapeutics in underserved communities.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
02/20/26	$75,000,000	Series B	Atlantic Partners Forbion Capital Partners Medicxi Pitango Growth Sanofi	undisclosed